Glenview Capital Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-1,364,449
Closed -$132M 56
2017
Q4
$132M Sell
1,364,449
-3,976,883
-74% -$375M 0.71% 39
2017
Q3
$475M Sell
5,341,332
-768,838
-13% -$58.5M 2.75% 13
2017
Q2
$443M Sell
6,110,170
-1,191,797
-16% -$80.1M 2.87% 13
2017
Q1
$476M Sell
7,301,967
-1,815,002
-20% -$114M 3.16% 12
2016
Q4
$571M Buy
9,116,969
+3,086,828
+51% +$188M 3.86% 7
2016
Q3
$380M Sell
6,030,141
-6,424,347
-52% -$416M 2.72% 13
2016
Q2
$771M Sell
12,454,488
-1,232,100
-9% -$75.1M 5.45% 5
2016
Q1
$782M Buy
13,686,588
+141,773
+1% +$7.9M 5.72% 5
2015
Q4
$802M Sell
13,544,815
-2,626,088
-16% -$151M 4.52% 6
2015
Q3
$880M Sell
16,170,903
-1,685,038
-9% -$110M 4.37% 4
2015
Q2
$1.2B Buy
17,855,941
+15,412,309
+631% +$1.01B 4.75% 3
2015
Q1
$143M Buy
+2,443,632
New +$148M 0.65% 50

Other funds holding ABBV